PSPH (Human) Recombinant Protein (Q01) - BIOGEN Científica
Characteristics of patients with progressive supranuclear palsy (PSP) in US health insurance claims data Progressive supranuclea
Biogen on Twitter: "#DYK progressive supranuclear palsy (#PSP) wasn't discovered until 1963 due to its resemblance to Parkinson's disease? #PSPAwarenessMonth https://t.co/59rxSezyHe" / Twitter
Biogen looks to M&A to overcome competition to its MS franchise | Fierce Pharma
AbbVie Discontinued a Drug Trial. Biogen Stock Is Falling. | Barron's
Biogen Study - CurePSP
These Clinical Study Results are provided for informational purposes only. The study listed may include approved and non
Biogen Ends Trial of Its Drug for PSP - CurePSP
Acompañamos a... - Pharmexx Argentina part of Ashfield Group | Facebook
Biogen Reports Top-Line Results from Phase 2 Study in Progressive Supranuclear Palsy | Biogen
FAQ on FDA Approval of Aducanumab - CurePSP
Biogen on Twitter: "Progressive Supranuclear Palsy (#PSP) Awareness Month may be over, but the work doesn't end here. #PSPAwareness https://t.co/oC0MNF0IVD" / Twitter
Biogen on Twitter: "#DYK…Progressive supranuclear palsy (#PSP) is a neurodegenerative disorder that affects the brain cells controlling balance, walking, coordination, eye movement, speech, swallowing and thinking. #AANAM https://t.co/uYb551MjJi" / Twitter
Biogen abandons tau antibody for Alzheimer's after phase 2 miss | pharmaphorum
Corio PSP™ – Detox RejuveNation
Biogen MA Inc. 225 Binney Street Cambridge, MA 02142 United States PROTOCOL NUMBER: 251PP301 / NCT03068468 Biogen Idec Research
Biogen pays $300M to Bristol-Myers for another potential Alzheimer's drug - Boston Business Journal
Biogen on Twitter: "We're dedicated to advancing research and development for movement disorders like progressive supranuclear palsy (#PSP). https://t.co/7NOueg0df4" / Twitter
Biogen chalks up another failure, but investors' eyes remain firmly on Alzheimer's | Fierce Biotech
What's in Biogen's Clinical Pipeline?
PSP — Coleen Heaver
☑️Biogen México — Supplier from Mexico, experience with UNOPS — Health, Laboratory & Measurement, Research, Science & Innovation sectors — DevelopmentAid
After Recent Tau Failure, Biogen Licenses Tau Therapeutic from Ionis for Alzheimer's Disease | BioSpace
PSP — Coleen Heaver
